[CL2-95014-002]-laysummary-2023.05.06.EN

Home » A Multicentre, Phase II Randomized Study, Open-label, With 2-arm Parallel Group, Comparing the Pharmacokinetics of the Liquid and the Lyophilized Formulations of Pegaspargase (S95014) in Treatment of Paediatric Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) » [CL2-95014-002]-laysummary-2023.05.06.EN

© 2025 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.

Accessibility